Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/18/17 → 2/13/20 |
Funding
- PRA Health Sciences (GS-US-384-1943)
- Gilead Sciences, Inc. (GS-US-384-1943)
Prot# GS-US-384-1943: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
- Rinella, Mary Eugenia (PD/PI)
Project: Research project